Erlonix
Erlonix is Erlotinib, an EGFR tyrosine kinase inhibitor. It is indicated for EGFR-positive NSCLC and selected pancreatic cancer regimens and works by blocking EGFR-mediated cellular proliferation signals.
Features
| Product Name | Erlonix |
| Generic Name | Erlotinib |
| Formulation | Tablet |
| Available Pack Size | 3X10's, 5X6's |
| Available Strength | 100MG, 150MG |